Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531
Topic overview
This study evaluates how accurately institutions assess image-defined risk factors (IDRFs) in intermediate-risk neuroblastoma patients compared to standardized central review. The research examines the reliability of IDRF-based staging criteria used in the International Neuroblastoma Risk Group classification system through prospective analysis of COG study ANBL0531 data.
Key takeaways
- INRG staging uses image-defined risk factors (IDRFs) to assess locoregional neuroblastoma extent before treatment.
- COG study ANBL0531 compared institutional IDRF assessments to standardized central review for quality assurance.
- Prospective validation of IDRF criteria helps standardize risk stratification in intermediate-risk neuroblastoma patients.
Keywords
Hashtags
Full article text
Full article text not available for this entry
How to cite: GlobalCastMD. Evaluation of Image-Defined Risk Factor (IDRF) Assessment in Patients With Intermediate-risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531. GlobalCastMD Medical Library. 2024-09-05. https://dev.library.globalcastmd.com/article/9125?via_space=staycurrentmd
Comments